---
title: "Amasse Capital Holdings Announces Board Resignations and New Director Appointments"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/275131771.md"
datetime: "2026-02-06T13:24:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275131771.md)
  - [en](https://longbridge.com/en/news/275131771.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275131771.md)
---

# Amasse Capital Holdings Announces Board Resignations and New Director Appointments

Amasse Capital Holdings Ltd. has announced changes to its board of directors effective 6 February 2026. Mr. Lo Mun Lam Raymond and Ms. Tsang Kwong Wan have resigned as executive directors. Mr. Cheung Pak To, Mr. Li Wing Sum Steven, and Dr. Yu Yuen Ping have stepped down as independent non-executive directors. New appointments include Mr. Chan Wai Kit, Mr. Xie Lei, Mr. Wu Peisheng, Ms. Li Xianchang, Mr. Fan Kaiye, and Ms. Jiang Dandan as executive directors, and Mr. Liu Zhanqing, Mr. Lin Haining, and Ms. Wong Chi Yan as independent non-executive directors. The composition of board committees has also been updated. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amasse Capital Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260206-12018432), on February 06, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [08168.HK](https://longbridge.com/en/quote/08168.HK.md)

## Related News & Research

- [Amasse Capital Holdings Announces CEO Resignation and Board Appointments](https://longbridge.com/en/news/274528576.md)
- [Amasse Capital Files HKEX Disclosure on Share Capital Increase With (Number) New Shares at (Price) Each](https://longbridge.com/en/news/274626487.md)
- [Joinn Laboratories sets board meeting to review first-quarter results](https://longbridge.com/en/news/283118236.md)
- [Hagar hosts investor presentation on FY2025/26 results, Q4 earnings](https://longbridge.com/en/news/283110626.md)
- [Xuanzhu Biopharma wins HKEX approval to list 357,245,794 converted H shares](https://longbridge.com/en/news/283112742.md)